433 related articles for article (PubMed ID: 27859670)
1. Leprosy reactions in postelimination stage: the Bangladesh experience.
Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
[TBL] [Abstract][Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
3. A study of leprosy reactions in a tertiary hospital in Delhi.
Sharma N; Koranne RV; Mendiratta V; Sharma RC
J Dermatol; 2004 Nov; 31(11):898-903. PubMed ID: 15729862
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
5. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
6. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and management of leprosy reaction in China in 2005.
Shen J; Liu M; Zhou M; Wengzhong L
Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for erythema nodosum leprosum.
Manandhar R; LeMaster JW; Roche PW
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
[TBL] [Abstract][Full Text] [Related]
9. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
10. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
Beuria MK; Mohanty KK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
13. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
14. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
Santaram V; Porichha D
Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
[TBL] [Abstract][Full Text] [Related]
15. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
Nery JA; Vieira LM; de Matos HJ; Gallo ME; Sarno EN
Rev Inst Med Trop Sao Paulo; 1998; 40(6):363-70. PubMed ID: 10436656
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
Kumar B; Dogra S; Kaur I
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
[TBL] [Abstract][Full Text] [Related]
18. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
[TBL] [Abstract][Full Text] [Related]
19. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
20. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.
Richardus JH; Finlay KM; Croft RP; Smith WC
Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
